MR imaging is indicated for mad cow disease diagnosis

Article

RI should be included among the World Health Organization's options for diagnosing sporadic Creutzfeldt-Jakob disease, which is associated with exposure to mad cow disease, according to Dr. Henriette Tschampa and colleagues at the Clinical University of Bonn, Germany.

MRI should be included among the World Health Organization's options for diagnosing sporadic Creutzfeldt-Jakob disease, which is associated with exposure to mad cow disease, according to Dr. Henriette Tschampa and colleagues at the Clinical University of Bonn, Germany.

The researchers enrolled 193 consecutive patients suspected of having the condition. In 442 scans, MR's sensitivity and specificity were nearly 70% and 85%, respectively, in patients with a clinical or postmortem sCJD diagnosis. Sensitivity and specificity for EEG and 14-3-3 protein analysis were 32% and 94%, and 91% and 44%, respectively, they reported at the RSNA meeting. Even though interpretation of MR scans may require some effort, the modality provides useful information that could narrow down an sCJD diagnosis.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.